Beta-Alanine
SupplementThe medical score is higher because meta-analyses [s2, s5] confirm consistent effects within specific performance domains (60–240 s). Community users, however, often experience the effects as less clear-cut in everyday use, as many strength athletes (who do not perform efforts within the target range) report no benefit [c3, c4].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Beta-alanine is one of the best-validated sports supplements for high-intensity efforts lasting 1–4 minutes: multiple meta-analyses confirm consistent performance improvements (ES 0.18–0.55), with muscle carnosine increases directly verified via biopsy. For pure strength training or endurance efforts beyond 4 minutes, the benefit is limited — powerlifters will likely feel nothing. The tingling (paresthesia) is harmless but real, and the main reason most users quit. Splitting doses into 0.8 g increments significantly reduces this effect.
Description
Non-essential amino acid that increases muscle carnosine levels and improves performance during high-intensity efforts of 1–4 minutes [s1, s2].
Beta-alanine (β-alanine) is a non-essential, non-proteinogenic amino acid that serves as a precursor to carnosine in the human body [s1]. Carnosine is a dipeptide composed of beta-alanine and histidine, stored in skeletal muscle where it acts as an intracellular buffer against acidosis [s1, s3]. Beta-alanine supplementation (typically 3.2–6.4 g/day) increases muscle carnosine content by 20–80% [s1]. This increase is dose-dependent and becomes pronounced after 4 weeks of regular intake [s4, s5]. The effect on athletic performance is most strongly documented for efforts between 60 and 240 seconds [s2, s3]. In meta-analytic evaluations, beta-alanine demonstrated a mean performance improvement of approximately 2.85% at a cumulative total dose of 179 g, with effect sizes (ES) between 0.18 and 0.55 depending on the exercise protocol [s2, s5]. The benefit for pure strength performance or very short efforts (< 60 s) is less clearly established [s2, s5]. Beta-alanine is also active as a neurotransmitter in the central nervous system and can cross the blood-brain barrier [s8]. Exploratory studies on cognitive effects in humans are available but are not conclusive [s8]. The most typical and well-known side effect is paresthesia (tingling, usually in the face, neck, and hands), which can occur at single doses above 0.8–1.6 g but is considered harmless [s3, s6].
Legal Status (DE)
In Germany, beta-alanine is commercially available as a dietary supplement. However, under EU law (Regulation EC No. 953/2009), beta-alanine is not explicitly listed as a permitted amino acid in dietary supplements, creating a legal grey area [s10]. In practice, it is nonetheless marketed as a dietary supplement and is widely available for purchase in Germany, Austria, and Switzerland. No BfR maximum quantity recommendations exist for beta-alanine [s10].
Mechanism of Action
Beta-alanine is the rate-limiting substrate for carnosine synthase in skeletal muscle [s1, s4]. Plasma beta-alanine concentration limits carnosine synthesis, as histidine is available in sufficient quantities [s1]. Carnosine (β-alanyl-L-histidine) acts as an intracellular proton buffer (pKa ≈ 6.83), neutralizing hydrogen ions (H⁺) generated during high-intensity exercise through anaerobic glycolysis [s1, s3]. This buffering mechanism delays the pH drop within the muscle cell and thereby the performance-impairing acidosis [s3]. Additionally, carnosine acts as a diffusible Ca²⁺/H⁺ exchanger: it transports Ca²⁺ back into the sarcoplasmic reticulum and H⁺ toward the cell membrane, which may improve calcium sensitivity of the muscle and thus contractile force (the so-called "carnosine shuttle hypothesis") [s4]. This mechanism has been described predominantly in cardiac myocytes and requires further confirmation in human skeletal muscle [s4]. Beta-alanine can cross the blood-brain barrier via active carrier transport and increase carnosine and homocarnosine levels in the brain [s8]. Carnosine in the CNS acts as a neurotransmitter and endogenous neuroprotective agent [s8]. Paresthesia arises from direct activation of sensory nerves (presumably Mas-related G-protein-coupled receptors, MrgPRD) by beta-alanine itself — independent of the carnosine mechanism [s6].
Dosing
Sportliche Leistung (hochintensiv, 1–4 min)
- Dose
- 3.2–6.4 g per day, divided into individual doses of 0.8–1.6 g
- Frequency
- 3–4× täglich verteilt
- Route
- oral
- Duration
- mindestens 4 Wochen, ideal 10–12 Wochen
- Timing
- No specific timing dependency established; distribution throughout the day reduces paresthesia
- With food
- optional
Ladeprotokoll (niedrige Parästhesie-Belastung)
- Dose
- 0.8 g every 3–4 hours (sustained-release or divided doses)
- Frequency
- 4–6× täglich
- Route
- oral
- Duration
- mindestens 4–12 Wochen
- Timing
- Even distribution throughout the day recommended
- With food
- empfohlen
Safety data are available for up to 6.4 g/day over several weeks [s3, s9]. No official maximum quantity recommendation from BfR or EFSA exists for beta-alanine [s10]. Long-term data beyond > 1 year are largely absent.
Sustained-release formulations can reduce paresthesia but showed no strength improvement in some studies despite high daily doses [s7]. A cumulative total dose of approximately 179 g (equivalent to ~56 days at 3.2 g/day) is associated with ~2.85% performance improvement [s5].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Parästhesie (Kribbeln/Brennen der Haut, meist Gesicht, Hals, Hände) Occurs with single doses >0.8–1.6 g; considered harmless and resolves within 60–90 minutes [s3, s6]. Mechanism: direct activation of sensory nerve receptors by beta-alanine [s6]. | häufig | leicht |
| Abfall des Taurinspiegels im Muskel Beta-alanine and taurine compete for the same transporter (TauT); sustained beta-alanine supplementation can reduce muscle taurine levels [s9]. Clinical relevance in humans unclear. | gelegentlich | leicht |
| Gastrointestinale Beschwerden (Übelkeit, Magenunbehagen) Occasionally reported at higher single doses; reducible by taking with meals [s3]. | selten | leicht |
Contraindications
Insufficient safety data available for pregnant or breastfeeding women [s9]. Use not recommended.
Safety in children and adolescents not established [s9].
Beta-alanine may interact with certain cardiac medications and drugs for the treatment of erectile dysfunction [s9]. Mechanism not fully elucidated; medical consultation recommended.
In impaired renal function, excretion of beta-alanine and its metabolites is altered. Direct nephrotoxicity has not been established, but safety studies in this population are lacking [s9].
Interactions
Synergistic
Frequently combined, as beta-alanine improves aerobic/anaerobic buffering and creatine supports phosphocreatine resynthesis. Additive effect on muscular endurance performance is plausible but not conclusively confirmed in high-quality RCTs [s3].
Both substances act as buffers against muscle acidosis via different mechanisms (intracellular vs. extracellular). Combined intake may act synergistically [s4].
Caution
Beta-alanine and taurine share the same membrane transporter (TauT) and compete for absorption. Simultaneous high-dose intake may reduce uptake of both substances [s9].
Possible interaction with cardiac medications and PDE-5 inhibitors (e.g., sildenafil, tadalafil); exact mechanisms not fully elucidated. Medical consultation recommended [s9].
Studies
Tier A — High Evidence
Outcome: Performance improvement during high-intensity exercise
Effect Size: Significant improvement at exercise durations of 60–240 s; ES ~0.18–0.55
Outcome: Mean performance improvement
Effect Size: ~2.85% improvement with 179 g total dose; ES 0.34–0.55 depending on protocol
Outcome: Exercise capacity and performance
Effect Size: Small to moderate effect; strongest evidence for 60–240 s exercise durations
Tier B — Moderate Evidence
Outcome: Muscle carnosine increase as a function of dose and duration
Effect Size: 20–80% increase in muscle carnosine content
Outcome: Brain carnosine/homocarnosine signal and cognitive function
Effect Size: No significant cognitive effect in this small sample
Tier C — Low Evidence
Outcome: Mechanism update (carnosine shuttle hypothesis, Ca²⁺/H⁺ exchange)
Effect Size: Mechanistically plausible; confirmation in human skeletal muscle pending
Community Evidence
Top reported benefits
- Improved endurance during high-intensity exercise (CrossFit, cycling, swimming)
- Noticeable delay of muscle failure during interval training
- Paresthesia (tingling) interpreted as a positive indicator of efficacy
- Good compatibility with creatine and caffeine in pre-workout formulations
Top reported issues
- Paresthesia (tingling) is perceived as bothersome by many users
- Strength athletes frequently report no perceptible effect
- No noticeable effect during pure strength exercises (< 60 s duration)
- Effect only onset after several weeks
Some users report that effects diminish quickly after discontinuation. Taurine competition is rarely discussed in the community, despite being mechanistically relevant [s9]. Skepticism regarding actual benefits for strength sports dominates in German bodybuilding forums [c3, c4].
Scientific Sources
- The Muscle Carnosine Response to Beta-Alanine Supplementation: A Systematic Review With Bayesian Individual and Aggregate Data E-Max Model and Meta-Analysis
Hobson RM, Harris RC, Martin D, et al. (2020). Frontiers in PhysiologyAPMID:32903696DOI - Stellungnahme des Arbeitskreises Lebensmittelchemischer Sachverständiger (ALS) – Beta-Alanin in Nahrungsergänzungsmitteln, 104. Sitzung 2014
Arbeitskreis Lebensmittelchemischer Sachverständiger (ALS), BVL (2014). Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL)ALink - β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis
Saunders B, Elliott-Sale K, Artioli GG, et al. (2017). British Journal of Sports MedicineAPMID:27797728DOI - Effects of Beta-Alanine on Muscle Carnosine and Exercise Performance: A Review of the Current Literature
Hobson RM, Saunders B, Ball G, et al. (2012). Journal of the International Society of Sports NutritionBPMID:22281276DOI - An Update on Beta-Alanine Supplementation for Athletes (SSE #208)
Stellingwerff T, Blancquaert L, Derave W (2022). Gatorade Sports Science Institute (Sports Science Exchange)BLink - Dosing strategies for β-alanine supplementation in strength and power performance: a systematic review
Freitas MC, Rossi FE, Lira FS, et al. (2025). Journal of the International Society of Sports NutritionADOI - Beta-Alanine: Performance Effects, Dosing Protocols, and Paresthesia
Examine.com Editorial Team (2024). Examine.comDLink - Effect of a sustained-release formulation of β-alanine on muscle carnosine and exercise performance
Décombaz J, Bauer C, Ith M, et al. (2012). Amino AcidsAPMID:22270875DOI - Effects of Beta-Alanine Supplementation on Brain Homocarnosine/Carnosine Signal and Cognitive Function: An Exploratory Study
Baguet A, Reyngoudt H, Pottier A, et al. (2015). PLOS ONEAPMID:25875162DOI - A Systematic Risk Assessment and Meta-Analysis on the Use of Oral Beta-Alanine Supplementation
Dolan E, Swinton PA, Painelli VS, et al. (2019). Advances in NutritionAPMID:30659319DOI
Community Sources
Storage
Unopened
Store in a dry place at room temperature, protected from direct sunlight.
Opened
Keep packaging tightly sealed; protect powder form from moisture.
Notes
No special refrigeration requirements. Observe shelf life as indicated by the manufacturer.